BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23538447)

  • 1. Apoptosis of osteosarcoma cultures by the combination of the cyclin-dependent kinase inhibitor SCH727965 and a heat shock protein 90 inhibitor.
    Fu W; Sharma SS; Ma L; Chu B; Bui MM; Reed D; Pledger WJ
    Cell Death Dis; 2013 Mar; 4(3):e566. PubMed ID: 23538447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dinaciclib (SCH727965) inhibits the unfolded protein response through a CDK1- and 5-dependent mechanism.
    Nguyen TK; Grant S
    Mol Cancer Ther; 2014 Mar; 13(3):662-74. PubMed ID: 24362465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DesA Prognostic Risk Model of LncRNAs in Patients With Acute Myeloid Leukaemia Based on TCGA Data.
    Ding W; Ling Y; Shi Y; Zheng Z
    Front Bioeng Biotechnol; 2022; 10():818905. PubMed ID: 35265597
    [No Abstract]   [Full Text] [Related]  

  • 5. A Novel Pyroptosis-Related Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Osteosarcoma.
    Zhang Y; He R; Lei X; Mao L; Jiang P; Ni C; Yin Z; Zhong X; Chen C; Zheng Q; Li D
    Front Genet; 2021; 12():780780. PubMed ID: 34899864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of miR-138 on the Function of Follicular Helper T Cells and the Differentiation of B Cells in Osteosarcoma.
    Wang Z; Liang J; Jiang S; Zhao G; Lu J; Jiang B
    Comput Math Methods Med; 2021; 2021():2057782. PubMed ID: 34858518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated macrophages in osteosarcoma.
    Zhao Y; Zhang B; Zhang Q; Ma X; Feng H
    J Zhejiang Univ Sci B; 2021 Nov; 22(11):885-892. PubMed ID: 34783219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
    Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
    Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Immune Landscape of Osteosarcoma: Implications for Prognosis and Treatment Response.
    Cascini C; Chiodoni C
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children.
    Jiang F; Miao XL; Zhang XT; Yan F; Mao Y; Wu CY; Zhou GP
    J Immunol Res; 2021; 2021():5523832. PubMed ID: 34337075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Lipid-Metabolism Genes Is Correlated With Immune Microenvironment and Predicts Prognosis in Osteosarcoma.
    Qian H; Lei T; Hu Y; Lei P
    Front Cell Dev Biol; 2021; 9():673827. PubMed ID: 33937273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration.
    Fu Y; Bao Q; Liu Z; He G; Wen J; Liu Q; Xu Y; Jin Z; Zhang W
    Front Cell Dev Biol; 2021; 9():633607. PubMed ID: 33816483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-purpose isocyanides produced by
    Raffa N; Won TH; Sukowaty A; Candor K; Cui C; Halder S; Dai M; Landero-Figueroa JA; Schroeder FC; Keller NP
    Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33593906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Immune-Related Genes
    Chen Z; Huang H; Wang Y; Zhan F; Quan Z
    Front Mol Biosci; 2020; 7():576298. PubMed ID: 33381518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Biology of Osteosarcoma.
    Czarnecka AM; Synoradzki K; Firlej W; Bartnik E; Sobczuk P; Fiedorowicz M; Grieb P; Rutkowski P
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9.
    Tan SF; Ni JX; Xiong H
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2271-2280. PubMed ID: 32196578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma.
    Ren L; Ruiz-Rodado V; Dowdy T; Huang S; Issaq SH; Beck J; Wang H; Tran Hoang C; Lita A; Larion M; LeBlanc AK
    Cancer Metab; 2020; 8():4. PubMed ID: 32158544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key biomarkers and immune infiltration in the synovial tissue of osteoarthritis by bioinformatics analysis.
    Cai W; Li H; Zhang Y; Han G
    PeerJ; 2020; 8():e8390. PubMed ID: 31988808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells.
    Yoshida K; Okamoto M; Sasaki J; Kuroda C; Ishida H; Ueda K; Ideta H; Kamanaka T; Sobajima A; Takizawa T; Tanaka M; Aoki K; Uemura T; Kato H; Haniu H; Saito N
    BMC Cancer; 2020 Jan; 20(1):25. PubMed ID: 31914969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer.
    Li N; Zhan X
    EPMA J; 2019 Sep; 10(3):273-290. PubMed ID: 31462944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.